151 related articles for article (PubMed ID: 20615745)
1. Levodopa response in dementia with lewy bodies: a 1-year follow-up study.
Lucetti C; Logi C; Del Dotto P; Berti C; Ceravolo R; Baldacci F; Dolciotti C; Gambaccini G; Rossi G; Bonuccelli U
Parkinsonism Relat Disord; 2010 Sep; 16(8):522-6. PubMed ID: 20615745
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.
Firbank MJ; Burn DJ; McKeith IG; O'Brien JT
Int J Geriatr Psychiatry; 2005 Aug; 20(8):776-82. PubMed ID: 16035122
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
[TBL] [Abstract][Full Text] [Related]
4. [Dementia with Lewy Bodies and its differentiation from Alzheimer's disease].
Ransmayr G; Katzenschlager R; Dal-Bianco P; Wenning G; Bancher C; Jellinger K; Schmidt R; Poewe W
Neuropsychiatr; 2007; 21(2):63-74. PubMed ID: 17640492
[TBL] [Abstract][Full Text] [Related]
5. Levodopa use and sleep in patients with dementia with Lewy bodies.
Molloy S; Minett T; O'Brien JT; McKeith IG; Burn DJ
Mov Disord; 2009 Mar; 24(4):609-12. PubMed ID: 19191343
[TBL] [Abstract][Full Text] [Related]
6. Dementia with Lewy bodies and Parkinson's disease.
McKeith IG; Mosimann UP
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S15-8. PubMed ID: 15109582
[TBL] [Abstract][Full Text] [Related]
7. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.
Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG
Mov Disord; 2008 Apr; 23(6):837-44. PubMed ID: 18307261
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease dementia--a first step?
Press DZ
N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
[No Abstract] [Full Text] [Related]
9. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
Frank C
Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
[TBL] [Abstract][Full Text] [Related]
10. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
[TBL] [Abstract][Full Text] [Related]
11. The role of levodopa in the management of dementia with Lewy bodies.
Molloy S; McKeith IG; O'Brien JT; Burn DJ
J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1200-3. PubMed ID: 16107351
[TBL] [Abstract][Full Text] [Related]
12. Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease.
Perneczky R; Drzezga A; Boecker H; Ceballos-Baumann AO; Granert O; Förstl H; Kurz A; Häussermann P
Dement Geriatr Cogn Disord; 2008; 26(5):475-81. PubMed ID: 18984958
[TBL] [Abstract][Full Text] [Related]
13. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
Larsson V; Aarsland D; Ballard C; Minthon L; Londos E
Int J Geriatr Psychiatry; 2010 Oct; 25(10):1030-8. PubMed ID: 20872929
[TBL] [Abstract][Full Text] [Related]
14. ["Red flags": when to be alerted and how to explore?].
Tison F
Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease: progression and mortality in the L-DOPA era.
Di Rocco A; Molinari SP; Kollmeier B; Yahr MD
Adv Neurol; 1996; 69():3-11. PubMed ID: 8615142
[No Abstract] [Full Text] [Related]
16. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
17. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
Gerschlager W; Bloem BR
Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
[No Abstract] [Full Text] [Related]
18. Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.
Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
Mov Disord; 2010 Mar; 25(4):489-93. PubMed ID: 20063406
[TBL] [Abstract][Full Text] [Related]
19. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
Apaydin H; Ahlskog JE; Parisi JE; Boeve BF; Dickson DW
Arch Neurol; 2002 Jan; 59(1):102-12. PubMed ID: 11790237
[TBL] [Abstract][Full Text] [Related]
20. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies.
Molloy SA; Rowan EN; O'Brien JT; McKeith IG; Wesnes K; Burn DJ
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1323-8. PubMed ID: 16952917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
